enherent Corp. (ENHT)
Syosset, NY, US
Enherent Corp. operates as a technology services firm primarily focused on the northeastern United States. The company provides specialized IT consulting and staffing solutions, designed to support clients by augmenting their internal resource needs across a spectrum of critical areas. These include project management, business analysis, systems and database architecture and design, application development, network engineering, and quality assurance and testing. Its application development portfolio encompasses a full lifecycle approach, from initial planning and design through application coding, rigorous testing, and final deployment. This applies to both enhancements for existing platforms and the creation of entirely new custom software. Furthermore, Enherent assists with the evaluation and implementation of third-party business applications. Regarding network and security services, Enherent provides comprehensive support, covering planning, architectural design, and engineering expertise to facilitate the construction, optimization, and security auditing of network infrastructures. This also extends to the deployment of software product licenses and essential computer hardware. The firm's systems integration capabilities involve conducting thorough assessments of applications, data, and technical environments to pinpoint existing deficiencies. Following this, it develops recommendations to close these gaps, often by leveraging current IT assets. Implementation then proceeds through a combination of custom application coding, deployment of software products, and integration of computer equipment, ultimately embedding new functionalities within the client's environment. Additionally, Enherent delivers advanced analytics solutions, utilizing text analytics technology to interpret and process unstructured, free-form textual data. Its diverse clientele spans sectors such as insurance, financial services, banking and capital markets, retail distribution, apparel, healthcare, pharmaceutical, and consumer goods. The company's primary office is situated in Syosset, New York.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -98.18% | -87.50% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Information Technology Services: +10.1%-60.8% Q3'10: -7.6% (vs Q3'09)
-
EPS growth Information Technology Services: +16.7%-193.9% Q3'10: +21.1% (vs Q3'09)
-
FCF margin FCF growth · Information Technology Services: +32.8%-4.1% Q3'10: +33.3% (vs Q3'09)
-
EBIT margin Information Technology Services: +9.0%-7.4% Q3'10: +2.5% (vs Q3'09)
-
ROIC Information Technology Services: +9.5%-45.3% Q3'10: +17.9% (vs Q3'09)
-
Share dilution Information Technology Services: +0.0%+0.0% Q3'10: +0.0% (vs Q3'09)
-
Debt / EBITDA Net debt/EBITDA · Information Technology Services: -0.83×-6.80× Q3'10: 8.18× (vs Q3'09)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2008-12-31 | TUDOR INVESTMENT CORP ET AL | 10% Owner | J-Other | D | Common Stock, $0.001 par value | 3,142,826 | 0.00 | — | 6,593,336 | — | ↗ |
| 2008-04-24 | TUDOR INVESTMENT CORP ET AL | 10% Owner | J-Other | D | Common Stock, $0.001 par value | 1,549,308 | 0.00 | — | 9,736,162 | — | ↗ |
| 2007-08-10 | TUDOR INVESTMENT CORP ET AL | 10% Owner | J-Other | A | Common Stock, $0.001 par value | 1,474,202 | 0.00 | — | 9,736,162 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Pamela A. Fredette | Chairman, Chief Executive Officer & President | 268.8K | female |
| Arunava De | Vice President of Finance & Controller | 109.4K | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ENHT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
